AGIO files Form 144 to sell 5,218 shares

AGIO filing notifies a proposed sale of 5,218 shares of common stock in connection with the vesting of restricted stock units, scheduled 03/02/2026.

Rhea-AI Filing Summary

AGIO filing notifies a proposed sale of 5,218 shares of common stock in connection with the vesting of restricted stock units, scheduled 03/02/2026. The filing also reports a prior sale of 2,932 shares on 12/30/2025 by James Burns.

Insights

Securities Counsel

Routine Form 144 notice of resale tied to RSU vesting; prior small sale disclosed.

The filing lists a proposed resale of 5,218 shares arising from RSU vesting on 03/02/2026, and discloses a prior sale of 2,932 shares on 12/30/2025 by James Burns. The entry follows standard resale notice procedures.

Cash‑flow treatment and post‑sale ownership figures are not provided in the excerpt; subsequent transaction reports or broker statements would show execution details.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does AGIO's Form 144 disclose about the March 2026 sale?

The Form 144 discloses a proposed sale of 5,218 shares tied to RSU vesting scheduled for 03/02/2026. It lists the transaction as a resale related to vested restricted stock units.

Who reported recent sales in the AGIO Form 144 filing?

The filing shows a prior sale by James Burns of 2,932 shares on 12/30/2025. That sale is reported in the "Securities Sold During The Past 3 Months" section.

Are proceeds or price details included in AGIO's Form 144 excerpt?

The excerpt does not state sale proceeds or per‑share price. The Form 144 lists share counts and dates but does not provide dollar amounts or execution proceeds in the provided text.

Does the Form 144 indicate who will receive sale proceeds for AGIO?

The filing links the 5,218 shares to RSU vesting and labels the source as the issuer, but it does not specify who will receive proceeds in the provided excerpt.

Is the March 2, 2026 transaction confirmed executed in AGIO's filing?

The Form 144 describes a proposed resale scheduled for 03/02/2026; the excerpt does not confirm execution or settlement of that transaction.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/02/2026 - 04:09 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001900772
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	AGIOS PHARMACEUTICALS, INC.
SEC File Number	001-36014
Address of Issuer	88 SIDNEY STREET CAMBRIDGE MASSACHUSETTS 02139
Phone	617-649-8600
Name of Person for Whose Account the Securities are To Be Sold	Burns James William
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	5218	157740.00	58592172	03/02/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	03/02/2026	Vesting of Restricted Stock Units	Issuer			5218	03/02/2026	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
James Burns 88 Sidney Street Cambridge MA 02139	Common Stock	12/30/2025	2932	79428.00

144: Remarks and Signature

Remarks
Date of Notice	03/02/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	03/01/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	William Cook, attorney-in-fact for Jim Burns
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)